Management

Inhibrx is a privately held, science-first, self-sustainable biotherapeutic company. Inhibrx developed an efficient and productive scientific and business approach to align the incentives of our scientific team, collaborators, biotech and pharmaceutical partners and investors to rapidly develop transformative therapeutics for patients in need.